Let-7 and cancer

MicroRNA Let-7: Role in Human Diseases and Drug Discovery

Volumn , Issue , 2013, Pages 109-123

  Fuziwara, Cesar Seigi ^a   Geraldo, Murilo Vieira ^a   Kimura, Edna Teruko ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892949137     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. Boyerinas, B., Park, S. M., Murmann, A. E., Gwin, K., Montag, A. G., Zillardt, M. R., Hua, Y. J., Lengyel, E., and Peter, M. E. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of MDR1. Int. J. Cancer. 2011.
2. Boyerinas, B., Park, S. M., Shomron, N., Hedegaard, M. M., Vinther, J., Andersen, J. S., Feig, C., Xu, J., Burge, C. B., and Peter, M. E. Identification of Let-7-regulated oncofetal genes. Cancer Res. 2008;68:2587-2591.
3. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., and Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U S A. 2004;101:2999-3004.
4. Chang, S. S., Jiang, W. W., Smith, I., Poeta, L. M., Begum, S., Glazer, C., Shan, S., Westra, W., Sidransky, D., and Califano, J. A. MicroRNA alterations in head and neck squamous cell carcinoma. Int. J. Cancer. 2008;123:2791-2797.
5. Childs, G., Fazzari, M., Kung, G., Kawachi, N., Brandwein-Gensler, M., McLemore, M., Chen, Q., Burk, R. D., Smith, R.V., Prystowsky, M. B., Belbin, T. J., and Schlecht, N. F. Low-level expression of microRNAs Let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol. 2009;174:736-745.
6. Chin, L. J., Ratner, E., Leng, S., Zhai, R., Nallur, S., Babar, I., Muller, R. U., Straka, E., Su, L., Burki, E. A., Crowell, R. E., Patel, R., Kulkarni, T., Homer, R., Zelterman, D., Kidd, K. K., Zhu, Y., Christiani, D. C., Belinsky, S. A., Slack, F. J., and Weidhaas, J. B. A SNP in a Let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res. 2008;68:8535-8540.
7. Christensen, B. C., Moyer, B. J., Avissar, M., Ouellet, L. G., Plaza, S. L., McClean, M. D., Marsit, C. J., and Kelsey, K. T. A Let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis. 2009;30:1003-1007.
8. Dahiya, N., Sherman-Baust, C. A., Wang, T. L., Davidson, B., Shih Ie, M., Zhang, Y., Wood, W., 3rd, Becker, K. G., and Morin, P. J. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One. 2008;3:e2436.
9. Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., Furth, E. E., Lee, W. M., Enders, G. H., Mendell, J. T., and Thomas-Tikhonenko, A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006;38:1060-1065.
10. Dong, Q., Meng, P., Wang, T., Qin, W., Qin, W., Wang, F., Yuan, J., Chen, Z., Yang, A., and Wang, H. MicroRNA Let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One. 2010;5:e10147.
11. Esquela-Kerscher, A. and Slack, F. J. OncomiRs-microRNAs with a role in cancer. Nat. Rev. Cancer. 2006;6:259-269.
12. Esquela-Kerscher, A., Trang, P., Wiggins, J. F., Patrawala, L., Cheng, A., Ford, L., Weidhaas, J. B., Brown, D., Bader, A. G., and Slack, F. J. The Let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 2008;7:759-764.
13. Facchini, L. M. and Penn, L. Z. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. Faseb. J. 1998;12:633-651.
14. Fusco, A. and Fedele, M. Roles of HMGA proteins in cancer. Nat. Rev. Cancer. 2007;7:899-910.
15. He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C. G., Franssila, K., Suster, S., Kloos, R. T., Croce, C. M., and De la Chapelle, A. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U S A. 2005a;102:19075-19080.
16. He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., and Hammond, S. M. A microRNA polycistron as a potential human oncogene. Nature. 2005b;435:828-833.
17. Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C. G., Alder, H., Calin, G. A., Menard, S., and Croce, C. M. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699-8707.
18. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011;61:69-90.
19. Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., Wilson, M., Wang, X., Shelton, J., Shingara, J., Chin, L., Brown, D., and Slack, F. J. The Let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 2007;67:7713-7722.
20. Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., and Slack, F. J. RAS is regulated by the Let-7 microRNA family. Cell. 2005;120:635-647.
21. King, C. E., Wang, L., Winograd, R., Madison, B. B., Mongroo, P. S., Johnstone, C. N., and Rustgi, A. K. LIN28B fosters colon cancer migration, invasion and transformation through Let-7-dependent and-independent mechanisms. Oncogene. 2011.
22. Krichevsky, A. M., and Gabriely, G. miR-21: a small multi-faceted RNA. J. Cell Mol. Med. 2009;13:39-53.
23. Kumar, M. S., Erkeland, S. J., Pester, R. E., Chen, C. Y., Ebert, M. S., Sharp, P. A., and Jacks, T. Suppression of non-small cell lung tumor development by the Let-7 microRNA family. Proc. Natl. Acad. Sci. U S A. 2008;105:3903-3908.
24. Lau, K. S. and Haigis, K. M. Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer. Mol. Cells. 2009;28:315-320.
25. Lee, J. W., Choi, C. H., Choi, J. J., Park, Y. A., Kim, S. J., Hwang, S. Y., Kim, W. Y., Kim, T. J., Lee, J. H., Kim, B. G., and Bae, D. S. Altered MicroRNA expression in cervical carcinomas. Clin. Cancer Res. 2008;14:2535-2542.
26. Lee, Y. S. and Dutta, A. The tumor suppressor microRNA Let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025-1030.
27. Liang, S., He, L., Zhao, X., Miao, Y., Gu, Y., Guo, C., Xue, Z., Dou, W., Hu, F., Wu, K., Nie, Y., and Fan, D. MicroRNA Let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One.2011;6:e18409.
28. Liu, Q., Lv, G. D., Qin, X., Gen, Y. H., Zheng, S. T., Liu, T., and Lu, X. M. Role of microRNA Let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol. Biol. Rep. 2011.
29. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., and Golub, T. R. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838.
30. Mayr, C., Hemann, M. T. and Bartel, D. P. Disrupting the pairing between Let-7 and Hmga2 enhances oncogenic transformation. Science. 2007;315:1576-1579.
31. Mendell, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133:217-222.
32. Meng, F., Henson, R., Wehbe-Janek, H., Smith, H., Ueno, Y., and Patel, T. The MicroRNA Let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J. Biol. Chem. 2007;282:8256-8264.
33. Moller, P., Koretz, K., Leithauser, F., Bruderlein, S., Henne, C., Quentmeier, A., and Krammer, P. H. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer. 1994;57:371-377.
34. Mongroo, P. S., Noubissi, F. K., Cuatrecasas, M., Kalabis, J., King, C. E., Johnstone, C. N., Bowser, M. J., Castells, A., Spiegelman, V. S., and Rustgi, A. K. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. Cancer Res. 2011;71:2172-2182.
35. Moss, E. G. and Tang, L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev. Biol. 2003;258:432-442.
36. Motoyama, K., Inoue, H., Nakamura, Y., Uetake, H., Sugihara, K., and Mori, M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to Let-7 microRNA family. Clin. Cancer Res. 2008;14:2334-2340.
37. Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A. H., Wewer, U. M., and Nielsen, F. C. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell Biol. 1999;19:1262-1270.
38. Noubissi, F. K., Elcheva, I., Bhatia, N., Shakoori, A., Ougolkov, A., Liu, J., Minamoto, T., Ross, J., Fuchs, S. Y., and Spiegelman, V. S. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature. 2006;441:898-901.
39. Ozen, M., Creighton, C. J., Ozdemir, M., and Ittmann, M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008;27:1788-1793.
40. Pallante, P., Visone, R., Ferracin, M., Ferraro, A., Berlingieri, M. T., Troncone, G., Chiappetta, G., Liu, C. G., Santoro, M., Negrini, M., Croce, C. M., and Fusco, A. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer. 2006;13:497-508.
41. Pan, L., Gong, Z., Zhong, Z., Dong, Z., Liu, Q., Le, Y., and Guo, J. Lin-28 reactivation is required for Let-7 repression and proliferation in human small cell lung cancer cells. Mol. Cell Biochem. 2011;355:257-263.
42. Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B., Muller, P., Spring, J., Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., Davidson, E., and Ruvkun, G. Conservation of the sequence and temporal expression of Let-7 heterochronic regulatory RNA. Nature. 2000;408:86-89.
43. Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., and Ruvkun, G. The 21-nucleotide Let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901-906.
44. Ricarte-Filho, J. C., Fuziwara, C. S., Yamashita, A. S., Rezende, E., Da-Silva, M. J., and Kimura, E. T. Effects of Let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer. Transl. Oncol. 2009;2:236-241.
45. Richards, M., Tan, S. P., Tan, J. H., Chan, W. K., and Bongso, A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem. Cells. 2004;22:51-64.
46. Roush, S. and Slack, F. J. The Let-7 family of microRNAs. Trends Cell Biol. 2008;18:505-516.
47. Sampson, V. B., Rong, N. H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petrelli, N. J., Dunn, S. P., and Krueger, L. J. MicroRNA Let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007;67:9762-9770.
48. Schultz, J., Lorenz, P., Gross, G., Ibrahim, S., and Kunz, M. MicroRNA Let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008;18:549-557.
49. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., Mitsudomi, T., and Takahashi, T. Reduced expression of the Let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753-3756.
50. Tsang, W. P. and Kwok, T. T. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis. 2008;13:1215-1222.
51. Visone, R., Pallante, P., Vecchione, A., Cirombella, R., Ferracin, M., Ferraro, A., Volinia, S., Coluzzi, S., Leone, V., Borbone, E., Liu, C. G., Petrocca, F., Troncone, G., Calin, G. A., Scarpa, A., Colato, C., Tallini, G., Santoro, M., Croce, C. M., and Fusco, A. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007;26:7590-7595.
52. Viswanathan, S. R., Powers, J. T., Einhorn, W., Hoshida, Y., Ng, T. L., Toffanin, S., O'Sullivan, M., Lu, J., Phillips, L. A., Lockhart, V. L., Shah, S. P., Tanwar, P. S., Mermel, C. H., Beroukhim, R., Azam, M., Teixeira, J., Meyerson, M., Hughes, T. P., Llovet, J. M., Radich, J., Mullighan, C. G., Golub, T. R., Sorensen, P. H., and Daley, G. Q. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009;41:843-848.
53. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C., and Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U S A. 2006;103:2257-2261.
54. Wang, S., Tang, Y., Cui, H., Zhao, X., Luo, X., Pan, W., Huang, X., and Shen, N. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun. 2011;12:149-154.
55. Wasylishen, A. R. and Penn, L. Z. Myc: the beauty and the beast. Genes Cancer. 2010;1:532-541.
56. Weidhaas, J. B., Babar, I., Nallur, S. M., Trang, P., Roush, S., Boehm, M., Gillespie, E., and Slack, F. J. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res. 2007;67:11111-11116.
57. Yu, C. C., Chen, Y. W., Chiou, G. Y., Tsai, L. L., Huang, P. I., Chang, C. Y., Tseng, L. M., Chiou, S. H., Yen, S. H., Chou, M. Y., Chu, P. Y., and Lo, W. L. MicroRNA Let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol. 2011;47:202-210.
58. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., and Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-1920.